Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review

Denosumab is a potent antiresorptive agent that substantially increases bone mineral density and reduces fracture rates at all skeletal sites for as long as it is administered. However, its favorable skeletal effects reverse quickly upon its discontinuation, because of a vast increase of osteoclast...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasilakis, Athanasios D., Makras, Polyzois, Yavropoulou, Maria P., Tabacco, Gaia, Naciu, Anda Mihaela, Palermo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796169/
https://www.ncbi.nlm.nih.gov/pubmed/33406802
http://dx.doi.org/10.3390/jcm10010152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796169/
https://www.ncbi.nlm.nih.gov/pubmed/33406802
http://dx.doi.org/10.3390/jcm10010152

Ejemplares similares